Preparation of tanshinone Ⅱ_A-glycyrrhetinic acid solid lipid nanoparticles and its inhibitory effect on acne.
10.19540/j.cnki.cjcmm.20210323.303
- Author:
Fang-Ning CHEN
1
;
Xiu-Li WANG
1
;
Rui-Rui XU
1
;
Xiao-Jie WANG
2
;
Jing-Hua RUAN
3
Author Information
1. Beijing University of Chinese Medicine Beijing 102488, China.
2. College of Bioengineering,Beijing Polytechnic Beijing 100176, China.
3. Guizhou University of Traditional Chinese Medicine Guiyang 550001, China.
- Publication Type:Journal Article
- Keywords:
acne;
glycyrrhetinic acid;
prescription screening;
solid lipid nanoparticles;
tanshinone Ⅱ_A
- MeSH:
Abietanes;
Acne Vulgaris/drug therapy*;
Animals;
Drug Carriers;
Glycyrrhetinic Acid;
Liposomes;
Mice;
Nanoparticles;
Particle Size;
Testosterone
- From:
China Journal of Chinese Materia Medica
2022;47(9):2449-2456
- CountryChina
- Language:Chinese
-
Abstract:
The optimal prescription of tanshinone Ⅱ_A(TSN)-glycyrrhetinic acid(GA) solid lipid nanoparticles(GT-SLNs) was explored and evaluated in vivo and in vitro, and its effect on acne after oral administration was investigated. The preparation processing and prescription were optimized and verified by single factor and response surface methodology. The in vitro release of GA and TSN in GT-SLNs was determined by ultra-performance liquid chromatography(UPLC). The effect of GT-SLNs on acne was investigated by the levels of sex hormones in mice, ear swelling model, and tissue changes in sebaceous glands, and the pharmacokinetics was evaluated. The 24-hour cumulative release rates of GA and TSN in SLNs were 65.87%±5.63% and 36.13%±2.31% respectively. After oral administration of GT-SLNs and the mixture of GA and TSN(GT-Mix), the AUC_(0-t) and AUC_(0-∞) of TSN in GT-SLNs were 1.98 times and 4.77 times those in the GT-Mix group, respectively, and the peak concentration of TSN in the GT-SLNs group was 17.2 times that in the GT-Mix group. After intragastric administration of GT-SLNs, the serum levels of testosterone(T) and the ratio of testosterone to estradiol(T/E2) in the GT-SLNs group significantly declined, and the sebaceous glands of mice were atrophied to a certain extent. The results demonstrated that obtained GT-SLNs with good encapsulation efficiency and uniform particle size could promote the release of GA and TSN. GT-SLNs displayed therapeutic efficacy on acne manifested by androgen increase, abnormal sebaceous gland secretion, and inflammatory damage.
